Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Helping families thrive in the face of uncertainty: Strengths based approaches to working with families affected by progressive neurological illness.
Candidate SNP Markers of Gender-Biased Autoimmune Complications of Monogenic Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.
Myelin Basic Protein-primed T Helper 2 Cells Suppress Microglial Activation via AlphaVBeta3 Integrin: Implications for Multiple Sclerosis.
Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis.
Bisphenol-A Impairs Myelination Potential During Development in the Hippocampus of the Rat Brain.
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: No.
Acute cervical segmental denervation in neuromyelitis optica spectrum disorder.
Memory impairment in multiple sclerosis: Relevance of hippocampal activation and hippocampal connectivity.
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy.
Two functional promoter polymorphisms of neuregulin 1 gene are associated with progressive forms of multiple sclerosis.
Four FCRL3 Gene Polymorphisms (FCRL3_3, _5, _6, _8) Confer Susceptibility to Multiple Sclerosis: Results from a Case-Control Study.
Genetic variation associated with the occurrence and progression of neurological disorders.
Amyotrophic lateral sclerosis is not linked to multiple sclerosis in a population based study.
CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald Criteria 2010: Commentary.
Blinded and unblinded internal pilot study designs for clinical trials with count data.
Relapsing MS patients more satisfied with Novartis oral drug Gilenya(TM) than standard injectable therapies, according to new study results at CMSC
Prevalence of epilepsy in a cohort of patients with multiple sclerosis.
Matrine regulates glutamate-related excitotoxic factors in experimental autoimmune encephalomyelitis.
Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus.
Disturbed function of the blood-cerebrospinal fluid barrier aggravates neuro-inflammation.
Impairment of visuospatial/visuoconstructional skills in multiple sclerosis patients: the correlation with regional lesion load and subcortical atrophy.
Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.
Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy.
Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases.
Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?
Pages
« first
‹ previous
…
626
627
628
629
630
631
632
633
634
…
next ›
last »